Morgan Stanley has revised its rating on Lemonade (LMND) stock, moving it from Overweight to Equalweight. The primary driver behind this downgrade is valuation, following a substantial run-up in LMND's share price over recent months.

Lemonade, an insurance technology company leveraging AI and behavioral economics, has seen its stock gain considerable traction. However, the analyst's view suggests that the current valuation no longer justifies an Overweight rating, implying that much of the near-term upside may already be priced in.

This downgrade comes as LMND reported revenues of $737.9 million, a robust 40.2% year-over-year increase for the fiscal year ending 2025-12-31. Despite strong top-line growth, the company still faces significant profitability challenges, with negative net margins of -22.5% and diluted EPS of -$2.24.

The market reaction to such downgrades can be swift, particularly for growth stocks with high valuations and negative profitability. Traders will be watching to see if this rating change triggers a wave of profit-taking or if the underlying growth narrative continues to support the stock.